273 related articles for article (PubMed ID: 15994457)
21. Selective androgen receptor modulators for the prevention and treatment of muscle wasting associated with cancer.
Dalton JT; Taylor RP; Mohler ML; Steiner MS
Curr Opin Support Palliat Care; 2013 Dec; 7(4):345-51. PubMed ID: 24189892
[TBL] [Abstract][Full Text] [Related]
22. Discovery and biological characterization of a novel series of androgen receptor modulators.
Zhou C; Wu G; Feng Y; Li Q; Su H; Mais DE; Zhu Y; Li N; Deng Y; Yang D; Wang MW
Br J Pharmacol; 2008 May; 154(2):440-50. PubMed ID: 18414397
[TBL] [Abstract][Full Text] [Related]
23. Nonsteroidal selective androgen receptor modulators enhance female sexual motivation.
Jones A; Hwang DJ; Duke CB; He Y; Siddam A; Miller DD; Dalton JT
J Pharmacol Exp Ther; 2010 Aug; 334(2):439-48. PubMed ID: 20444881
[TBL] [Abstract][Full Text] [Related]
24. Comparative safety evaluation of selective androgen receptor modulators and anabolic androgenic steroids.
Choi SM; Lee BM
Expert Opin Drug Saf; 2015; 14(11):1773-85. PubMed ID: 26401842
[TBL] [Abstract][Full Text] [Related]
25. Recent advances in the development of selective androgen receptor modulators.
Zhang X; Lanter JC; Sui Z
Expert Opin Ther Pat; 2009 Sep; 19(9):1239-58. PubMed ID: 19505196
[TBL] [Abstract][Full Text] [Related]
26. Selective androgen receptor modulators activate the canonical prostate cancer androgen receptor program and repress cancer growth.
Nyquist MD; Ang LS; Corella A; Coleman IM; Meers MP; Christiani AJ; Pierce C; Janssens DH; Meade HE; Bose A; Brady L; Howard T; De Sarkar N; Frank SB; Dumpit RF; Dalton JT; Corey E; Plymate SR; Haffner MC; Mostaghel EA; Nelson PS
J Clin Invest; 2021 May; 131(10):. PubMed ID: 33998604
[TBL] [Abstract][Full Text] [Related]
27. Analysis of the growing public interest in selective androgen receptor modulators.
Efimenko IV; Chertman W; Masterson TA; Dubin JM; Ramasamy R
Andrologia; 2021 Dec; 53(11):e14238. PubMed ID: 34510504
[TBL] [Abstract][Full Text] [Related]
28. Structural basis for accommodation of nonsteroidal ligands in the androgen receptor.
Bohl CE; Miller DD; Chen J; Bell CE; Dalton JT
J Biol Chem; 2005 Nov; 280(45):37747-54. PubMed ID: 16129672
[TBL] [Abstract][Full Text] [Related]
29. General structure-activity correlations of antihormones.
Teutsch G; Nique F; Lemoine G; Bouchoux F; Cérède E; Gofflo D; Philibert D
Ann N Y Acad Sci; 1995 Jun; 761():5-28. PubMed ID: 7625749
[No Abstract] [Full Text] [Related]
30. Novel, non-steroidal, selective androgen receptor modulators (SARMs) with anabolic activity in bone and muscle and improved safety profile.
Rosen J; Negro-Vilar A
J Musculoskelet Neuronal Interact; 2002 Mar; 2(3):222-4. PubMed ID: 15758439
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics and pharmacodynamics of LGD-3303 [9-chloro-2-ethyl-1-methyl-3-(2,2,2-trifluoroethyl)-3H-pyrrolo-[3,2-f]quinolin-7(6H)-one], an orally available nonsteroidal-selective androgen receptor modulator.
Vajda EG; López FJ; Rix P; Hill R; Chen Y; Lee KJ; O'Brien Z; Chang WY; Meglasson MD; Lee YH
J Pharmacol Exp Ther; 2009 Feb; 328(2):663-70. PubMed ID: 19017848
[TBL] [Abstract][Full Text] [Related]
32. Steroidal androgens and nonsteroidal, tissue-selective androgen receptor modulator, S-22, regulate androgen receptor function through distinct genomic and nongenomic signaling pathways.
Narayanan R; Coss CC; Yepuru M; Kearbey JD; Miller DD; Dalton JT
Mol Endocrinol; 2008 Nov; 22(11):2448-65. PubMed ID: 18801930
[TBL] [Abstract][Full Text] [Related]
33. Selective androgen receptor modulator activity of a steroidal antiandrogen TSAA-291 and its cofactor recruitment profile.
Hikichi Y; Yamaoka M; Kusaka M; Hara T
Eur J Pharmacol; 2015 Oct; 765():322-31. PubMed ID: 26335395
[TBL] [Abstract][Full Text] [Related]
34. Selective androgen receptor modulators (SARMs) negatively regulate triple-negative breast cancer growth and epithelial:mesenchymal stem cell signaling.
Narayanan R; Ahn S; Cheney MD; Yepuru M; Miller DD; Steiner MS; Dalton JT
PLoS One; 2014; 9(7):e103202. PubMed ID: 25072326
[TBL] [Abstract][Full Text] [Related]
35. Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity.
Yarrow JF; McCoy SC; Borst SE
Steroids; 2010 Jun; 75(6):377-89. PubMed ID: 20138077
[TBL] [Abstract][Full Text] [Related]
36. Selective androgen receptor modulators in preclinical and clinical development.
Narayanan R; Mohler ML; Bohl CE; Miller DD; Dalton JT
Nucl Recept Signal; 2008; 6():e010. PubMed ID: 19079612
[TBL] [Abstract][Full Text] [Related]
37. Nonsteroidal progesterone receptor modulators: structure activity relationships.
Winneker RC; Fensome A; Wrobel JE; Zhang Z; Zhang P
Semin Reprod Med; 2005 Feb; 23(1):46-57. PubMed ID: 15714389
[TBL] [Abstract][Full Text] [Related]
38. Identification of anabolic selective androgen receptor modulators with reduced activities in reproductive tissues and sebaceous glands.
Schmidt A; Harada SI; Kimmel DB; Bai C; Chen F; Rutledge SJ; Vogel RL; Scafonas A; Gentile MA; Nantermet PV; McElwee-Witmer S; Pennypacker B; Masarachia P; Sahoo SP; Kim Y; Meissner RS; Hartman GD; Duggan ME; Rodan GA; Towler DA; Ray WJ
J Biol Chem; 2009 Dec; 284(52):36367-36376. PubMed ID: 19846549
[TBL] [Abstract][Full Text] [Related]
39. Effect of B-ring substitution pattern on binding mode of propionamide selective androgen receptor modulators.
Bohl CE; Wu Z; Chen J; Mohler ML; Yang J; Hwang DJ; Mustafa S; Miller DD; Bell CE; Dalton JT
Bioorg Med Chem Lett; 2008 Oct; 18(20):5567-70. PubMed ID: 18805694
[TBL] [Abstract][Full Text] [Related]
40. [Bone and Men's Health. Bone selective androgen receptor modulators].
Furuya K
Clin Calcium; 2010 Feb; 20(2):225-33. PubMed ID: 20118515
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
